Impact on Survival of Regular Postoperative Surveillance for Patients with Early Breast Cancer

The purpose of this study is to evaluate the role of regular postoperative surveillance to improve the prognosis of patients with breast cancer after curative surgery. We retrospectively analyzed the medical records of 4,119 patients who received curative surgery for breast cancer at Samsung Medical...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research and treatment 2015, 47(4), , pp.765-773
Hauptverfasser: Lee, Ji Yun, Lim, Sung Hee, Lee, Min-Young, Kim, Haesu, Kim, Moonjin, Kim, Sungmin, Jung, Hyun Ae, Sohn, Insuk, Gil, Won Ho, Lee, Jeong Eon, Kim, Seok Won, Nam, Seok Jin, Ahn, Jin Seok, Im, Young-Hyuck, Park, Yeon Hee
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The purpose of this study is to evaluate the role of regular postoperative surveillance to improve the prognosis of patients with breast cancer after curative surgery. We retrospectively analyzed the medical records of 4,119 patients who received curative surgery for breast cancer at Samsung Medical Center between January 2000 and September 2008. Patients were divided into two groups (group I, regular postoperative surveillance; group II, control group) according to their post-therapy follow-up status for the first 5 years after surgery. Among the 3,770 patients selected for inclusion, groups I and II contained 3,300 (87%) and 470 (13%) patients, respectively. The recurrence rates at 5 years for groups I and II were 10.6% and 16.4%, respectively (hazard ratio, 0.85; 95% confidence interval [CI], 0.67 to 1.09; p=0.197). The 10-year mortality cumulative rates were 8.8% for group I and 25.4% for group II (hazard ratio, 0.28; 95% CI, 0.22 to 0.35; p < 0.001). In multivariate analysis for recurrence-free survival (RFS), age over 40 years (p < 0.001), histologic grade 1 (p < 0.001), and pathologic stage I (p < 0.001) were associated with longer RFS but not with follow-up status. Multivariate analysis for overall survival (OS) revealed that patients in group I showed significantly improved OS (hazard ratio, 0.29; 95% CI, 0.23 to 0.37; p < 0.001). Additionally, age over 40 years, histologic grade I, and pathologic stage I were independent prognostic factors for OS. Regular follow-up for patients with breast cancer after primary surgery resulted in clinically significant improvements in patient OS.
ISSN:1598-2998
2005-9256
DOI:10.4143/crt.2014.168